In 2018, Grégoire Courtine, PhD, associate professor at the Swiss Federal Institute of Technology Lausanne (EPFL) and Jocelyne Bloch, MD, neurosurgeon at Lausanne University Hospital (CHUV), published a study showing that three patients with chronic paraplegia regained the ability to walk through a targeted neurotechnology which uses electrical stimulation to reactivate spinal neurons.
Now, the team is reporting an enhanced system with more sophisticated implants controlled by AI software. In this work, personalized spinal cord electrical stimulation—using electrode paddles designed specifically for spinal cord injuries—has been shown to restore independent motor movements within a few hours of the onset of therapy in three patients with complete sensorimotor paralysis.
These newer implants can stimulate the region of the spinal cord that activates the trunk and leg muscles. Thanks to this new technology, three patients with complete spinal cord injury were able to walk again outside the lab.
“All three patients were able to stand, walk, pedal, swim, and control their torso movements in just one day, after their implants were activated!” said Courtine. “That’s thanks to the specific stimulation programs we wrote for each type of activity. Patients can select the desired activity on the tablet, and the corresponding protocols are relayed to the pacemaker in the abdomen.”
This work is published in Nature Medicine, in the article titled, “Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis.”
Electrical stimulation of the spinal cord is a promising therapeutic option for restoring motor function in people with spinal cord injury. Stimulation approaches so far have provided continuous electrical stimulation of the spinal cord in patients through the use of re-purposed neurotechnologies that were originally designed to treat pain. However, these re-purposed electrical stimulation devices fail to stimulate all the nerves in the spinal cord associated with leg and trunk movements, which may limit the recovery of all motor functions.
The team designed a new electrode paddle that targets all nerves associated with leg and trunk movements in the spinal cord. They combined this technology with a personalized computational framework which allowed for the precise positioning of the electrode paddle for each patient and the personalization of activity-dependent stimulation programs.
“Our breakthrough here is the longer, wider implanted leads with electrodes arranged in a way that corresponds exactly to the spinal nerve roots,” said Bloch. “That gives us precise control over the neurons regulating specific muscles.”
This optimized spinal cord–stimulation approach was then shown to rapidly restore independent walking and other motor activities, such as cycling and swimming, in three patients (all men, between 29 and 41 years of age) with complete sensorimotor paralysis, within a single day. Neurorehabilitation further helped the patients to be able to conduct these activities within their communities.
These findings—which form part of an ongoing clinical trial (NCT02936453)—highlight the superior efficacy of purpose-built, personalized spinal cord–stimulation approaches, presenting a therapy that could mediate clinically meaningful improvements in people with a broad range of spinal cord injury severities.